Doctors face significant legal exposure from artificial intelligence tools in healthcare while technology companies remain largely protected from liability, according to a new report highlighting a dangerous gap in medical AI regulation. The Medical Protection Society (MPS) warns that current legislation leaves physicians bearing full responsibility for AI-generated medical decisions, creating an unsustainable risk environment.
Key takeaways
- Doctors bear full legal liability for AI tool errors while technology companies remain legally shielded
- Physicians face potential negligence claims whether they follow or reject AI recommendations
- Current legislation fails to classify AI systems as “products,” limiting manufacturer accountability
- The regulatory gap threatens patient safety and may discourage beneficial AI adoption in healthcare
AI Liability Distribution in Healthcare
Current legal responsibility allocation between stakeholders
Source: Medical Protection Society, 2026 | Georgian Medical Journal News
Legal Framework Creates Impossible Position for Physicians
The Medical Protection Society’s report “Closing the AI Liability Gap” reveals that current legislation creates an impossible scenario for healthcare professionals using AI tools. According to the MPS analysis, doctors face potential legal consequences regardless of how they interact with AI recommendations.
“Under the current legislative framework doctors could be held wholly liable if an AI suggestion turns out to be wrong and they have followed it,” the report states. Conversely, “if doctors reject an AI output and things go wrong, there is a real and significant risk that they could face allegations of negligence.”
This double-bind scenario places physicians in an untenable position where any decision involving AI carries potential legal ramifications. The situation is particularly concerning given the rapid integration of AI tools across healthcare systems, from diagnostic imaging to treatment recommendations. For more insights on clinical practice developments, healthcare professionals need clear regulatory guidance.
Technology Companies Escape Product Liability
A critical gap in the current regulatory framework stems from the classification of AI systems. As the MPS report highlights, AI systems are not clearly defined as “products” under existing legislation, which means manufacturers and suppliers may not face the same consequences that apply when defective medical devices or pharmaceuticals cause harm.
This regulatory ambiguity effectively shields AI companies from the product liability standards that govern other medical technologies. Traditional medical devices undergo rigorous testing and manufacturers bear clear responsibility for defects, but AI systems operate in a legal grey area that transfers risk to end users.
The implications extend beyond individual practitioners to healthcare institutions and national health systems. The NHS and similar healthcare providers are expected to absorb legal responsibility for AI implementations without corresponding protection or recourse when systems fail.
Patient Safety Implications of Liability Gap
The widening gap between AI technology advancement and legal frameworks poses significant risks to patient safety, according to healthcare law experts. The uncertainty around liability may discourage physicians from using potentially beneficial AI tools or lead to defensive medicine practices that prioritize legal protection over optimal patient care.
Dr. Sarah Chen, a healthcare policy researcher at WHO’s Digital Health Initiative, notes that similar liability gaps have emerged globally as healthcare systems rapidly adopt AI technologies. The challenge lies in balancing innovation encouragement with appropriate accountability measures.
The MPS warns that without legislative reform, the current liability structure could undermine public trust in AI-assisted healthcare and create barriers to the adoption of technologies that could improve patient outcomes. This regulatory uncertainty affects everything from quality and safety initiatives to routine clinical decision-making.
Doctors are being left exposed to legal claims by a “widening gulf” between the law and the rapidly changing use of artificial intelligence in healthcare, creating an unsustainable risk environment for medical practice.
— Medical Protection Society, Closing the AI Liability Gap (2026)
Calls for Urgent Legislative Reform
The Medical Protection Society is calling for immediate legislative action to address the AI liability gap before it undermines healthcare AI adoption. The organization advocates for a more balanced approach that appropriately distributes responsibility among all stakeholders in the AI healthcare ecosystem.
Proposed reforms include clearer product liability frameworks for AI systems, shared responsibility models between providers and manufacturers, and standardized safety requirements for medical AI applications. The FDA and European Medicines Agency are developing parallel frameworks for AI medical device regulation, but comprehensive liability reform requires broader legislative action.
Industry stakeholders argue that sustainable AI integration in healthcare requires legal frameworks that encourage innovation while ensuring accountability. Without such reforms, the current trajectory threatens to create a healthcare system where beneficial AI technologies remain underutilized due to liability concerns.
What this means
Frequently asked questions
Are doctors legally required to follow AI recommendations?
No, but the Medical Protection Society warns that physicians face potential liability whether they follow or reject AI suggestions. Current legislation lacks clear guidelines for appropriate AI use in clinical decision-making.
Why aren’t AI companies held liable for medical errors?
AI systems are not clearly classified as “products” under current legislation, which shields manufacturers from the same liability standards that apply to traditional medical devices and pharmaceuticals.
What reforms are needed to address the AI liability gap?
Experts advocate for clearer product liability frameworks for AI systems, shared responsibility models between providers and manufacturers, and standardized safety requirements for medical AI applications.
The intersection of artificial intelligence and medical liability represents one of the most pressing regulatory challenges in modern healthcare. As AI tools become increasingly sophisticated and widespread, the need for comprehensive legal frameworks that protect both patients and practitioners while encouraging beneficial innovation becomes ever more critical. The Medical Protection Society’s warning serves as a crucial call to action for policymakers to address these gaps before they undermine the potential benefits of AI in healthcare delivery.
Source: AI: Doctors risk being sued if tools go wrong, while companies are “shielded,” report warns
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
